Organization
Sage Therapeutics
14 clinical trials
Clinical trial
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Study of SAGE-324 for the Treatment of Essential TremorStatus: Active (not recruiting), Estimated PCD: 2024-05-01
Clinical trial
A 28-Day Randomized, Placebo-Controlled, Double-Blind, Parallel Groups and Normative Comparison Study to Evaluate the Effect of SAGE-718 on Functioning Capacity in Participants With Huntington's DiseaseStatus: Active (not recruiting), Estimated PCD: 2024-09-01
Clinical trial
A Phase 3, Open-Label, 1-Year Study of the Safety, Tolerability, and Need for Re-Treatment With SAGE-217 in Adult Subjects With Major Depressive DisorderStatus: Completed, Estimated PCD: 2023-06-22
Clinical trial
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's DiseaseStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
An Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Brexanolone in the Treatment of Adult Participants With TinnitusStatus: Completed, Estimated PCD: 2023-11-21
Clinical trial
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of SAGE-718 in Parkinson's Disease Cognitive ImpairmentStatus: Completed, Estimated PCD: 2024-01-17
Clinical trial
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's DiseaseStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Clinical trial
A Phase 2, Double-Blind, Placebo-controlled, Randomized Study Evaluating the Efficacy, Safety, and Tolerability of Sage-324 in the Treatment of Individuals With Essential TremorStatus: Completed, Estimated PCD: 2021-02-01
Clinical trial
An Open-Label Evaluation of the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's DiseaseStatus: Completed, Estimated PCD: 2021-09-21
Clinical trial
A Phase 3, Multicenter, Open-label Safety Study to Evaluate the Long-term Safety and Tolerability of SAGE-718 in Participants With Huntington's DiseaseStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
An Open-Label Evaluation of the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive ImpairmentStatus: Completed, Estimated PCD: 2022-03-25
Clinical trial
An Open-label Study of the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential TremorStatus: Recruiting, Estimated PCD: 2027-09-01
Clinical trial
A Phase 1, Study to Evaluate the Pharmacokinetics and Safety of Zuranolone in Adolescents (12 to 17 Years of Age) With Major Depressive DisorderStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
Assessment of Safe-use Conditions for Administration of ZULRESSO in a Home SettingStatus: Completed, Estimated PCD: 2022-07-14